CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
145 hedge funds and large institutions have $322M invested in Cymabay Therapeutics in 2020 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 41 increasing their positions, 36 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
52% less call options, than puts
Call options by funds: $1.9M | Put options by funds: $3.98M
Holders
145
Holding in Top 10
2
Calls
$1.9M
Puts
$3.98M
Top Buyers
| 1 | +$5M | |
| 2 | +$4.88M | |
| 3 | +$4.63M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.73M |
| 5 |
BlackRock
New York
|
+$1.47M |
Top Sellers
| 1 | -$12.4M | |
| 2 | -$9.53M | |
| 3 | -$8.63M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$7.67M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$3.63M |